Literature DB >> 2500784

Cost effectiveness of two interventions for reducing outpatient prescribing costs.

M A Steele1, D T Bess, V L Franse, S E Graber.   

Abstract

This prospective, randomized, controlled trial, based in a Veterans Administration Hospital general medicine clinic, compared the cost effectiveness of two behaviorally oriented interventions designed to reduce physicians' drug prescribing costs. Clinical pharmacists visited one group of 11 physicians during weekly clinic sessions to counterdetail the prescribing of certain targeted drugs. A second group of 10 physicians were given data each week comparing their individual prescribing costs to those of their colleagues (peer-comparison feedback). A control group of 10 physicians received neither intervention. Written patient-specific suggestions for cost-effective prescribing were employed in both intervention groups. Baseline prescribing costs were monitored through the hospital's computer during a three-month, preintervention period and a seven-month intervention period. The 2026 written suggestions made by the doctors of pharmacy resulted in 613 (30.3 percent) prescribing changes, including deletion, substitution, or change in dosage of targeted drugs. There were no intergroup differences in the response to written suggestions. However, the group receiving face-to-face visits from the clinical pharmacists achieved lower average prescription costs than the control group during seven of eight months. Intergroup differences were statistically significant (p less than 0.05) during three of the last five months of the study. The face-to-face meeting intervention was cost-effective, saving +478 per physician over seven months after accounting for Pharm.D. salary costs. There was no significant decrease in the number of prescriptions written by the face-to-face group compared with the control group, suggesting that drug substitution rather than deletion was the method used by physicians to lower drug costs. No savings resulted from the use of peer-comparison feedback. We conclude that personal visits by a Pharm.D. are a cost-effective technique for reducing physicians' prescribing costs, and are superior to peer-comparison feedback.

Entities:  

Mesh:

Year:  1989        PMID: 2500784     DOI: 10.1177/106002808902300612

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  19 in total

1.  Changing doctor prescribing behaviour.

Authors:  P S Gill; M Mäkelä; K M Vermeulen; N Freemantle; G Ryan; C Bond; T Thorsen; F M Haaijer-Ruskamp
Journal:  Pharm World Sci       Date:  1999-08

2.  Practice visits as a tool in quality improvement: mutual visits and feedback by peers compared with visits and feedback by non-physician observers.

Authors:  P van den Hombergh; R Grol; H J van den Hoogen; W J van den Bosch
Journal:  Qual Health Care       Date:  1999-09

Review 3.  Cost effectiveness of continuing professional development in health care: a critical review of the evidence.

Authors:  C A Brown; C R Belfield; S J Field
Journal:  BMJ       Date:  2002-03-16

Review 4.  Drug utilisation studies as tools in health economics.

Authors:  J A Sacristán; J Soto
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

5.  Do physicians take cost into account when making prescribing decisions?

Authors:  P Denig; F M Haaijer-Ruskamp
Journal:  Pharmacoeconomics       Date:  1995-10       Impact factor: 4.981

6.  Impact of feedback and peer review on prescribing.

Authors:  F M Haaijer-Ruskamp; P Denig
Journal:  Occas Pap R Coll Gen Pract       Date:  1995-02

7.  Effect of physician profiling on utilization. Meta-analysis of randomized clinical trials.

Authors:  E A Balas; S A Boren; G D Brown; B G Ewigman; J A Mitchell; G T Perkoff
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

8.  A brief overview of academic detailing in Canada: Another role for pharmacists.

Authors:  Margaret Jin; Terryn Naumann; Loren Regier; Shawn Bugden; Michael Allen; Lena Salach; Kristen Chelak; Nancy Blythe; Antony Gagnon; Lisa Dolovich
Journal:  Can Pharm J (Ott)       Date:  2012-05

9.  Drug prices and third party payment: do they influence medication selection?

Authors:  J E Hux; C D Naylor
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

10.  The physician and pharmacist team. An effective approach to cholesterol reduction.

Authors:  P E Bogden; L M Koontz; P Williamson; R D Abbott
Journal:  J Gen Intern Med       Date:  1997-03       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.